OptiNose Inc (OPTN)
1.29
+0.10
(+8.86%)
USD |
NASDAQ |
May 16, 16:00
1.18
-0.11
(-8.53%)
After-Hours: 20:00
OptiNose Free Cash Flow: -32.43M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -32.43M |
| December 31, 2023 | -20.86M |
| September 30, 2023 | -45.38M |
| June 30, 2023 | -58.29M |
| March 31, 2023 | -58.81M |
| December 31, 2022 | -67.71M |
| September 30, 2022 | -66.77M |
| June 30, 2022 | -58.99M |
| March 31, 2022 | -68.37M |
| December 31, 2021 | -77.10M |
| September 30, 2021 | -79.60M |
| June 30, 2021 | -85.56M |
| March 31, 2021 | -86.83M |
| Date | Value |
|---|---|
| December 31, 2020 | -86.75M |
| September 30, 2020 | -85.69M |
| June 30, 2020 | -85.19M |
| March 31, 2020 | -89.55M |
| December 31, 2019 | -91.37M |
| September 30, 2019 | -93.63M |
| June 30, 2019 | -103.14M |
| March 31, 2019 | -99.99M |
| December 31, 2018 | -93.51M |
| September 30, 2018 | -88.07M |
| June 30, 2018 | -72.12M |
| March 31, 2018 | -53.85M |
| December 31, 2017 | -38.09M |
Free Cash Flow Range, Past 5 Years
-103.14M
Minimum
Jun 2019
-20.86M
Maximum
Dec 2023
-72.10M
Average
-78.35M
Median
Free Cash Flow Benchmarks
| Zevra Therapeutics Inc | -45.66M |
| Madrigal Pharmaceuticals Inc | -391.12M |
| Viking Therapeutics Inc | -54.87M |
| CytomX Therapeutics Inc | -92.34M |
| Spero Therapeutics Inc | -33.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.02M |
| Cash from Investing (Quarterly) | -0.022M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow Per Share (Quarterly) | -0.1958 |
| Free Cash Flow to Equity (Quarterly) | -22.47M |
| Free Cash Flow Yield | -22.39% |